Following oral administration of radiolabeled zafirlukast to volunteers, urinary excretion accounts for approximately 10% from the dose and the remainder is excreted in feces. Zafirlukast just isn't detected in urine. Zafirlukast is thoroughly hepatically metabolized by an enzyme termed CYP2C9. Zafirlukast inhibits the action of CYP3A4, bringing about drug-drug interactions https://km0441680234.develop-blog.com/41475781/the-greatest-guide-to-lysotracker-red